VetClick
Menu Menu
Login

VetClick

/ News
Friday, 29th March 2024 | 4,186 veterinary jobs online | 103 people actively seeking work | 5,479 practices registered

Veterinary Industry News

Send us your news

Vetergesic Now Available For Use On Horses

13 years ago
4688 views

Posted
19th April, 2011 18h12


The benefit of a well sedated patient that is easier to handle, revives smoothly better and is more comfortable in recovery, is now available to equine practitioners. Vetergesic (buprenorphine), the UK’s most commonly used injectable opiate for small animal use, is now registered for use in horses. Horses head Developed and manufactured in the UK, Alstoe took over marketing the product 11 years ago and since that time has taken the product to the UK’s number one opiate1 . Two years ago they further improved Vetergesic by introducing the Multi-Dose Pack. This allows veterinary surgeons to more easily manage the larger liquid volumes required in horses. The product potentiates sedative drugs for standing sedation or routine premedication and provides profound centrally acting analgesic effects for up to nine hours. In routine procedures, this allows good recoveries and a rapid return to normal behaviour patterns. Studies carried out at Bristol University confirmed that in a thermal anti-nociceptive study that Vetergesic showed significantly better analgesic effects than butorphanol. Field studies carried out in the UK also confirmed that when combined with a sedative, Vetergesic can provide up to 60 minutes of operating time, with smooth and quick recoveries. “We have invested heavily in this product and are confident that the rewards enjoyed by small animal vets will also be appreciated by their equine colleagues,” says John Nellis of Alstoe. “We call Vetergesic ‘the thoroughbred of pain management’.” Vetergesic Multidose is available for dogs, cats and horses in a 10 ml vial. Alstoe offers an hour long explanatory seminar, which can be delivered directly to practice members. An 8 page brochure and ‘pocket-sized’ dose chart are also available. Further details on this may be obtained on request to Alstoe on Tel: 01347 878606 or email: [email protected] Reference: 1. Gfk March 2011.

More from


You might be interested in...